Shares of Boston Scientific Corporation (BSX) plunged nearly 15% on Wednesday, marking their sharpest single-day drop in months, even as the medical device maker posted solid fourth-quarter earnings and revenue growth. The stock was impacted by a cautious outlook for 2026.
The stock is currently trading at $76.81, down $14.78 or 16.14%, on the NYSE. The stock opened at $91.54 after closing Tuesday at $91.59.
The company reported fourth-quarter earnings of $672 million or $0.45 per share, up from $566 million, or $0.38 per share a year earlier. On an adjusted basis, earnings rose to $0.80 per share, while revenue climbed 15.9% to $5.29 billion.
For the full year, the company forecast adjusted earnings of $3.43 to $3.49 per share on net sales growth of 10.5% to 11.5%. Analysts see earnings of $3.47 per share.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.